NOVARTIS AG (NVS)
$155.02
Scores poorly across most models. Proceed with caution.
No data
Score based on 0 of 5 models — limited data
Is NOVARTIS AG a Good Investment in 2026?
NOVARTIS AG (NVS) scores 0.0 out of 10 on AlphaStocks' composite model, earning a No data rating. NOVARTIS AG ranks #1127 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Limited Data
Financial health check (9 signals)
Buffett
Limited Data
Business quality & competitive moat
Graham
Limited Data
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is NOVARTIS AG (NVS) a good investment?
What is NOVARTIS AG's Piotroski F-Score?
Is NVS overvalued or undervalued?
How does NVS compare to other Health Care stocks?
Similar Stocks
Compare NVS with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer